BrainStorm advances ALS cell therapy with FDA-backed trial design
CGTLive - 10-Jul-2024New phase 3b study aims to resolve manufacturing challenges and support regulatory approval
The Live Forever Club is evolving. Subscribe to the newsletter to be the first to hear about this important change.
An online platform providing news and insights on cell and gene therapies
CGTLive is a leading online platform focused on delivering news and insights about cell and gene therapies. It covers key developments in the biotechnology and pharmaceutical sectors, particularly the advancements in gene therapy, immunotherapy, and regenerative medicine. The site offers up-to-date coverage on clinical trials, regulatory updates, industry trends, and the scientific breakthroughs driving the future of personalized medicine. CGTLive serves as a trusted resource for professionals in the life sciences, from researchers to healthcare providers, with a focus on the commercialization and application of cutting-edge therapeutic innovations.
Visit website: https://www.cgtlive.com/
Details last updated 18-Nov-2024
New phase 3b study aims to resolve manufacturing challenges and support regulatory approval
Multistem combats inflammation to improve trauma recovery